Folkers K, Osterborg A, Nylander M, Morita M, Mellstedt H
Institute for Biomedical Research, University of Texas at Austin, 78712, USA.
Biochem Biophys Res Commun. 1997 May 19;234(2):296-9. doi: 10.1006/bbrc.1997.6522.
New data on blood levels of vitamin Q10 in 116 cancer patients reveal an incidence of 23.1% of patients (N=17) with breast cancer whose blood levels were below 0.5 microg/ml. The incidence of breast cancer cases with levels below 0.6 microg/ml was 38.5%. The incidence is higher (p<0.05) than that for a group of ordinary people. Patients (N=15) with myeloma showed a mean blood level of 0.67 +/- 0.17 microg/ml. The incidence of a vitamin Q10 blood level below 0.7 microg/ml for these 15 cases of myeloma was 53.3%, which is higher (p<0.05) than the 24.5% found for a group of ordinary people.
116名癌症患者血液中维生素Q10水平的新数据显示，乳腺癌患者中血液水平低于0.5微克/毫升的发生率为23.1%（N = 17）。血液水平低于0.6微克/毫升的乳腺癌病例发生率为38.5%。该发生率高于普通人群组（p<0.05）。骨髓瘤患者（N = 15）的血液平均水平为0.67±0.17微克/毫升。这15例骨髓瘤患者中维生素Q10血液水平低于0.7微克/毫升的发生率为53.3%，高于普通人群组的24.5%（p<0.05）。
